Back to search

Article

Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: Treatment goals and approaches to functional recovery

2023-03-08

Abstract excerpt

<h4>Background: </h4> Schizophrenia is mostly a chronic disorder whose symptoms include psychosis, negative symptoms and cognitive dysfunction. Poor adherence is common and related relapse can impair outcomes. Long-acting injectable antipsychotics (LAIs) may promote treatment adherence and decrease the likelihood of relapse and rehospitalization. Using LAIs in first-episode psychosis (FEP) and early-phase (EP) sch...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
345df79a-7f4a-5346-a5ee-50d58fcccdfc
DOI
10.21203/rs.3.rs-2594278/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: Treatment goals and approaches to functional recoveryDOI 10.21203/rs.3.rs-2594278/v1
Clinical Decision-Making in the Treatment of Schizophrenia: Focus on Long-Acting Injectable AntipsychoticsSemantic proximity
Use of Long-Acting Injectable Antipsychotics in Inpatients with Schizophrenia Spectrum Disorder in an Academic Psychiatric Hospital in SwitzerlandSemantic proximity
Health resource utilization and cost before versus after initiation of second-generation long-acting injectable antipsychotics among adults with schizophrenia in Alberta, Canada: a retrospective, observational single-arm studySemantic proximity
Shared decision-making interventions in the choice of antipsychotic prescription in people living with psychosis (SHAPE): protocol for a realist reviewSemantic proximity
Development and validation of a personalised antipsychotic selection tool for first-line treatment in severe mental illnessSemantic proximity
Aripiprazole, olanzapine and haloperidol in the long-term treatment of schizophrenia : the rationale & development of the GiSAS pragmatic randomized controlled trial, a consideration and empirical study of factors associated with recruitment (the GiSAS survey) and the concept of endpoints using a secondary analysis of existing data and a preliminary analysis of GiSAS trial dataSemantic proximity
Assessing demographic and clinical characteristics and healthcare resource utilization of patients with schizophrenia with inadequate response to antipsychotic treatmentSemantic proximity
Guide for recommendations on specific drug-related off-label treatment in palliative care: A Group Delphi processSemantic proximity
DREAMSPHEN: a randomised controlled study comparing dose reduction of antipsychotics vs maintenance treatment in schizophrenia spectrum disorder after stratification based on patients' psychotic phenotype - study protocol of a personalised medicine approach.Semantic proximity
Management of Antipsychotics in Primary Care: Insights from Healthcare Professionals and Policy Makers in the UKSemantic proximity
[Translational research for mental disorder -schizophrenia].Semantic proximity
Prescribing trends for the same patients with schizophrenia over 20 yearsSemantic proximity
Select a neighboring publication to make it the new centre.